Literature DB >> 29375298

Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Adam Labadorf1,2, Seung H Choi3, Richard H Myers1,2,3.   

Abstract

Huntington's and Parkinson's Diseases (HD and PD) are neurodegenerative disorders that share some pathological features but are disparate in others. For example, while both diseases are marked by aberrant protein aggregation in the brain, the specific proteins that aggregate and types of neurons affected differ. A better understanding of the molecular similarities and differences between these two diseases may lead to a more complete mechanistic picture of both the individual diseases and the neurodegenerative process in general. We sought to characterize the common transcriptional signature of HD and PD as well as genes uniquely implicated in each of these diseases using mRNA-Seq data from post mortem human brains in comparison to neuropathologically normal controls. The enriched biological pathways implicated by HD differentially expressed genes show remarkable consistency with those for PD differentially expressed genes and implicate the common biological processes of neuroinflammation, apoptosis, transcriptional dysregulation, and neuron-associated functions. Comparison of the differentially expressed (DE) genes highlights a set of consistently altered genes that span both diseases. In particular, processes involving nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) and transcription factor cAMP response element-binding protein (CREB) are the most prominent among the genes common to HD and PD. When the combined HD and PD data are compared to controls, relatively few additional biological processes emerge as significantly enriched, suggesting that most pathways are independently seen within each disorder. Despite showing comparable numbers of DE genes, DE genes unique to HD are enriched in far more coherent biological processes than the DE genes unique to PD, suggesting that PD may represent a more heterogeneous disorder. The complexity of the biological processes implicated by this analysis provides impetus for the development of better experimental models to validate the results.

Entities:  

Keywords:  Huntington disease; Parkinson disease; bioinformatics and computational biology; immune system; mRNA-seq; neurodegenerative diseases; neuroinflammation

Year:  2018        PMID: 29375298      PMCID: PMC5768647          DOI: 10.3389/fnmol.2017.00430

Source DB:  PubMed          Journal:  Front Mol Neurosci        ISSN: 1662-5099            Impact factor:   5.639


  74 in total

1.  A solution to the problem of separation in logistic regression.

Authors:  Georg Heinze; Michael Schemper
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

2.  Sepiapterin reductase expression is increased in Parkinson's disease brain tissue.

Authors:  Jennifer E Tobin; Jing Cui; Jemma B Wilk; Jeanne C Latourelle; Jason M Laramie; Ann C McKee; Mark Guttman; Samer Karamohamed; Anita L DeStefano; Richard H Myers
Journal:  Brain Res       Date:  2007-01-08       Impact factor: 3.252

3.  A new TRAIL in Alzheimer's disease therapy.

Authors:  Dan Frenkel
Journal:  Brain       Date:  2015-01       Impact factor: 13.501

4.  DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis.

Authors:  Guangchuang Yu; Li-Gen Wang; Guang-Rong Yan; Qing-Yu He
Journal:  Bioinformatics       Date:  2014-10-17       Impact factor: 6.937

Review 5.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 7.  Multiple dopamine functions at different time courses.

Authors:  Wolfram Schultz
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

8.  Robust rank aggregation for gene list integration and meta-analysis.

Authors:  Raivo Kolde; Sven Laur; Priit Adler; Jaak Vilo
Journal:  Bioinformatics       Date:  2012-01-12       Impact factor: 6.937

Review 9.  RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders.

Authors:  Mercè Canal; Joan Romaní-Aumedes; Núria Martín-Flores; Víctor Pérez-Fernández; Cristina Malagelada
Journal:  Front Cell Neurosci       Date:  2014-10-02       Impact factor: 5.505

10.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

View more
  18 in total

Review 1.  Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Manuj Ahuja; Bobby Thomas
Journal:  Mol Cell Neurosci       Date:  2019-10-20       Impact factor: 4.314

2.  Differential gene expression in the cortical sulcus compared to the gyral crest within the early stages of chronic traumatic encephalopathy.

Authors:  Jonathan D Cherry; Filisia Agus; Erin Dixon; Bertrand Huber; Victor E Alvarez; Jesse Mez; Ann C McKee; Adam Labadorf; Thor D Stein
Journal:  Free Neuropathol       Date:  2021-08-17

3.  Transcriptomic profiles in Parkinson's disease.

Authors:  Lille Kurvits; Freddy Lättekivi; Ene Reimann; Liis Kadastik-Eerme; Kristjan M Kasterpalu; Sulev Kõks; Pille Taba; Anu Planken
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-04

4.  The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain.

Authors:  Filisia Agus; Diego Crespo; Richard H Myers; Adam Labadorf
Journal:  BMC Med Genomics       Date:  2019-10-16       Impact factor: 3.063

5.  Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.

Authors:  Ayush Noori; Aziz M Mezlini; Bradley T Hyman; Alberto Serrano-Pozo; Sudeshna Das
Journal:  Neurobiol Dis       Date:  2020-12-19       Impact factor: 5.996

6.  RNA Sequencing of Human Peripheral Blood Cells Indicates Upregulation of Immune-Related Genes in Huntington's Disease.

Authors:  Miguel A Andrade-Navarro; Katja Mühlenberg; Eike J Spruth; Nancy Mah; Adrián González-López; Tommaso Andreani; Jenny Russ; Matthew R Huska; Enrique M Muro; Jean-Fred Fontaine; Vyacheslav Amstislavskiy; Alexei Soldatov; Wilfried Nietfeld; Erich E Wanker; Josef Priller
Journal:  Front Neurol       Date:  2020-11-27       Impact factor: 4.003

7.  A glycomics and proteomics study of aging and Parkinson's disease in human brain.

Authors:  Rekha Raghunathan; John D Hogan; Adam Labadorf; Richard H Myers; Joseph Zaia
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

Review 8.  Data science in neurodegenerative disease: its capabilities, limitations, and perspectives.

Authors:  Sepehr Golriz Khatami; Sarah Mubeen; Martin Hofmann-Apitius
Journal:  Curr Opin Neurol       Date:  2020-04       Impact factor: 6.283

Review 9.  Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.

Authors:  Olakunle J. Onaolapo; Adejoke Y. Onaolapo; Olugbenga A. Olowe; Mojisola O. Udoh; David O. Udoh; Thomas I. Nathaniel
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 10.  Regulation of Social Stress and Neural Degeneration by Activity-Regulated Genes and Epigenetic Mechanisms in Dopaminergic Neurons.

Authors:  Clement Kent; Pavan Agrawal
Journal:  Mol Neurobiol       Date:  2020-08-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.